241 related articles for article (PubMed ID: 18690432)
1. [18F]EF3 is not superior to [18F]FMISO for PET-based hypoxia evaluation as measured in a rat rhabdomyosarcoma tumour model.
Dubois L; Landuyt W; Cloetens L; Bol A; Bormans G; Haustermans K; Labar D; Nuyts J; Grégoire V; Mortelmans L
Eur J Nucl Med Mol Imaging; 2009 Feb; 36(2):209-18. PubMed ID: 18690432
[TBL] [Abstract][Full Text] [Related]
2. Tumor hypoxia imaging in orthotopic liver tumors and peritoneal metastasis: a comparative study featuring dynamic 18F-MISO and 124I-IAZG PET in the same study cohort.
Riedl CC; Brader P; Zanzonico P; Reid V; Woo Y; Wen B; Ling CC; Hricak H; Fong Y; Humm JL
Eur J Nucl Med Mol Imaging; 2008 Jan; 35(1):39-46. PubMed ID: 17786438
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of hypoxia in an experimental rat tumour model by [(18)F]fluoromisonidazole PET and immunohistochemistry.
Dubois L; Landuyt W; Haustermans K; Dupont P; Bormans G; Vermaelen P; Flamen P; Verbeken E; Mortelmans L
Br J Cancer; 2004 Nov; 91(11):1947-54. PubMed ID: 15520822
[TBL] [Abstract][Full Text] [Related]
4. A comparative study of the hypoxia PET tracers [¹⁸F]HX4, [¹⁸F]FAZA, and [¹⁸F]FMISO in a preclinical tumor model.
Peeters SG; Zegers CM; Lieuwes NG; van Elmpt W; Eriksson J; van Dongen GA; Dubois L; Lambin P
Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):351-9. PubMed ID: 25491505
[TBL] [Abstract][Full Text] [Related]
5. Comparative pharmacokinetics, biodistribution, metabolism and hypoxia-dependent uptake of [18F]-EF3 and [18F]-MISO in rodent tumor models.
Mahy P; De Bast M; de Groot T; Cheguillaume A; Gillart J; Haustermans K; Labar D; Grégoire V
Radiother Oncol; 2008 Dec; 89(3):353-60. PubMed ID: 18649964
[TBL] [Abstract][Full Text] [Related]
6. Preclinical validation of the hypoxia tracer 2-(2-nitroimidazol-1-yl)- N-(3,3,3-[(18)F]trifluoropropyl)acetamide, [(18)F]EF3.
Mahy P; De Bast M; Leveque PH; Gillart J; Labar D; Marchand J; Gregoire V
Eur J Nucl Med Mol Imaging; 2004 Sep; 31(9):1263-72. PubMed ID: 15197503
[TBL] [Abstract][Full Text] [Related]
7. Correlation of [18F]FMISO autoradiography and pimonidazole [corrected] immunohistochemistry in human head and neck carcinoma xenografts.
Troost EG; Laverman P; Philippens ME; Lok J; van der Kogel AJ; Oyen WJ; Boerman OC; Kaanders JH; Bussink J
Eur J Nucl Med Mol Imaging; 2008 Oct; 35(10):1803-11. PubMed ID: 18421457
[TBL] [Abstract][Full Text] [Related]
8. Comparison of three
Dos Santos SN; Wuest M; Jans HS; Woodfield J; Nario AP; Krys D; Dufour J; Glubrecht D; Bergman C; Bernardes ES; Wuest F
Nucl Med Biol; 2023; 124-125():108383. PubMed ID: 37651917
[TBL] [Abstract][Full Text] [Related]
9. NanoPET imaging of [(18)F]fluoromisonidazole uptake in experimental mouse tumours.
Wyss MT; Honer M; Schubiger PA; Ametamey SM
Eur J Nucl Med Mol Imaging; 2006 Mar; 33(3):311-8. PubMed ID: 16258762
[TBL] [Abstract][Full Text] [Related]
10. Determination of tumour hypoxia with [18F]EF3 in patients with head and neck tumours: a phase I study to assess the tracer pharmacokinetics, biodistribution and metabolism.
Mahy P; Geets X; Lonneux M; Levêque P; Christian N; De Bast M; Gillart J; Labar D; Lee J; Grégoire V
Eur J Nucl Med Mol Imaging; 2008 Jul; 35(7):1282-9. PubMed ID: 18317752
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the biodistribution of two hypoxia markers [18F]FETNIM and [18F]FMISO in an experimental mammary carcinoma.
Grönroos T; Bentzen L; Marjamäki P; Murata R; Horsman MR; Keiding S; Eskola O; Haaparanta M; Minn H; Solin O
Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):513-20. PubMed ID: 14722675
[TBL] [Abstract][Full Text] [Related]
12. A Comparative Study of Noninvasive Hypoxia Imaging with 18F-Fluoroerythronitroimidazole and 18F-Fluoromisonidazole PET/CT in Patients with Lung Cancer.
Wei Y; Zhao W; Huang Y; Yu Q; Zhu S; Wang S; Zhao S; Hu X; Yu J; Yuan S
PLoS One; 2016; 11(6):e0157606. PubMed ID: 27322586
[TBL] [Abstract][Full Text] [Related]
13. Comparison of [18F]-FMISO, [18F]-FAZA and [18F]-HX4 for PET imaging of hypoxia--a simulation study.
Wack LJ; Mönnich D; van Elmpt W; Zegers CM; Troost EG; Zips D; Thorwarth D
Acta Oncol; 2015; 54(9):1370-7. PubMed ID: 26203928
[TBL] [Abstract][Full Text] [Related]
14. Determination of tumour hypoxia with the PET tracer [18F]EF3: improvement of the tumour-to-background ratio in a mouse tumour model.
Christian N; Bol A; De Bast M; Labar D; Lee J; Mahy P; Grégoire V
Eur J Nucl Med Mol Imaging; 2007 Sep; 34(9):1348-54. PubMed ID: 17334763
[TBL] [Abstract][Full Text] [Related]
15. Iodine-124-labeled iodo-azomycin-galactoside imaging of tumor hypoxia in mice with serial microPET scanning.
Zanzonico P; O'Donoghue J; Chapman JD; Schneider R; Cai S; Larson S; Wen B; Chen Y; Finn R; Ruan S; Gerweck L; Humm J; Ling C
Eur J Nucl Med Mol Imaging; 2004 Jan; 31(1):117-28. PubMed ID: 14523586
[TBL] [Abstract][Full Text] [Related]
16. Comparative evaluation of [
Nakata N; Kiriu M; Okumura Y; Zhao S; Nishijima KI; Shiga T; Tamaki N; Kuge Y; Matsumoto H
Nucl Med Biol; 2019 Mar; 70():39-45. PubMed ID: 30836255
[TBL] [Abstract][Full Text] [Related]
17. Assessment of regional tumor hypoxia using 18F-fluoromisonidazole and 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone) positron emission tomography: Comparative study featuring microPET imaging, Po2 probe measurement, autoradiography, and fluorescent microscopy in the R3327-AT and FaDu rat tumor models.
O'Donoghue JA; Zanzonico P; Pugachev A; Wen B; Smith-Jones P; Cai S; Burnazi E; Finn RD; Burgman P; Ruan S; Lewis JS; Welch MJ; Ling CC; Humm JL
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1493-502. PubMed ID: 15817355
[TBL] [Abstract][Full Text] [Related]
18. ¹⁸F-HX4 hypoxia imaging with PET/CT in head and neck cancer: a comparison with ¹⁸F-FMISO.
Chen L; Zhang Z; Kolb HC; Walsh JC; Zhang J; Guan Y
Nucl Med Commun; 2012 Oct; 33(10):1096-102. PubMed ID: 22836736
[TBL] [Abstract][Full Text] [Related]
19. High reproducibility of tumor hypoxia evaluated by 18F-fluoromisonidazole PET for head and neck cancer.
Okamoto S; Shiga T; Yasuda K; Ito YM; Magota K; Kasai K; Kuge Y; Shirato H; Tamaki N
J Nucl Med; 2013 Feb; 54(2):201-7. PubMed ID: 23321456
[TBL] [Abstract][Full Text] [Related]
20. Autoradiographic and small-animal PET comparisons between (18)F-FMISO, (18)F-FDG, (18)F-FLT and the hypoxic selective (64)Cu-ATSM in a rodent model of cancer.
Dence CS; Ponde DE; Welch MJ; Lewis JS
Nucl Med Biol; 2008 Aug; 35(6):713-20. PubMed ID: 18678357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
